Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Endocrinology

• Publication date

  2001-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2265.2001.01271.xPMID 11422108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

  2000cited by this paper
• Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.

  2000cited by this paper
• Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.

  2000cited by this paper
• The effects of testosterone on osteoporosis in men

  1999cited by this paper
• Effect of testosterone treatment on bone mineral density in men over 65 years of age.

  1999cited by this paper
• Osteoporosis in Men

  1999cited by this paper
• Osteoporosis in men.

  1999cited by this paper
• Androgens and Bone: Clinical Aspects

  1999cited by this paper
• Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men.

  1998cited by this paper
• Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.

  1998cited by this paper
• Osteoporosis in men.

  1997cited by this paper
• Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.

  1997cited by this paper
• Anabolic effects of parathyroid hormone on bone.

  1997cited by this paper
• Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.

  1997cited by this paper
• Effect of testosterone and estradiol in a man with aromatase deficiency.

  1997cited by this paper
• Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.

  1996cited by this paper
• Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women.

  1996cited by this paper
• Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.

  1996cited by this paper
• Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.

  1995cited by this paper
• Effect of testosterone on bone density and bone metabolism in adolescent male hypogonadism.

  1995cited by this paper
• Site-specific effect of testosterone on bone mineral density in male hypogonadism.

  1995cited by this paper
• Osteoporosis in men.

  1995cited by this paper
• Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.

  1995cited by this paper
• Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.

  1994cited by this paper
• Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.

  1994cited by this paper
• Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities.

  1993cited by this paper
• Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study

  1993cited by this paper
• Pathogenesis of vertebral crush fractures in men.

  1992cited by this paper
• Effects of testosterone supplementation in the aging male.

  1992cited by this paper
• Testosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case‐Control Study

  1992cited by this paper
• Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study.

  1992cited by this paper
• Androgen receptors in osteoblast-like cell lines

  1991cited by this paper
• Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis

  1991cited by this paper
• Does Hypogonadism Contribute to the Occurrence of a Minimal Trauma Hip Fracture in Elderly Men?

  1991cited by this paper
• Osteoporosis in Men: Diagnosis, Pathophysiology, and Prevention

  1990cited by this paper
• Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells.

  1990cited by this paper
• Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats

  1990cited by this paper
• Identification of androgen receptors in normal human osteoblast-like cells.

  1989cited by this paper
• Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein.

  1989cited by this paper
• Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein.

  1989cited by this paper
• Osteoporosis in men with idiopathic hypogonadotropic hypogonadism.

  1987cited by this paper
• Osteoporosis in men with hyperprolactinemic hypogonadism.

  1986cited by this paper
• Printed in U.S.A. Copyright © 1997 by The Endocrine Society The Effects of Androgen Deficiency on Murine Bone Remodeling and Bone Mineral Density Are Mediated via

  year unknowncited by this paper

• Steroid hormones and nephrolithiasis: regulation of urine components metabolism and inflammation

  2026cites this paper
• Heart Failure and Osteoporosis: Shared Challenges in the Aging Population

  2025cites this paper
• PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men

  2025cites this paper
• Does Body Mass Index predict changes in body composition and metabolic markers in response to testosterone therapy?

  2025cites this paper
• Sarcopenic Obesity and Hormones: A Narrative Review

  2025cites this paper
• Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism

  2025cites this paper
• Indications for testosterone therapy in men

  2024cites this paper
• Modulation of circulating free testosterone fraction by testosterone, dihydrotestosterone, and estradiol during testosterone replacement therapy

  2024cites this paper
• Serum total testosterone is associated with phosphate and calcium excretion in response to oral phosphate loading in healthy middle‐aged males

  2024cites this paper
• Short-Term Changes in Bone Metabolism Among Transgender Men Starting Gender-Affirming Hormone Therapy: A Systematic Review and Meta-analysis

  2024cites this paper
• Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial

  2023cites this paper
• Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy

  2022cites this paper
• Testosterone supplementation and bone parameters: a systematic review and meta-analysis study

  2022cites this paper
• Role of sex steroids hormones in the regulation of bone metabolism in men: Evidence from clinical studies.

  2022influential citation
• Testosterone Replacement Therapy in Hypogonadal Men.

  2022cites this paper
• Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism

  2022cites this paper
• Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations

  2022influential citation
• Biochemical markers of bone turnover in osteoporosis

  2021cites this paper
• Age-Related Testosterone Deficiency Merits Treatment

  2021cites this paper
• Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.

  2021cites this paper
• Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol

  2021influential citation
• Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review

  2021cites this paper
• Bone in heart failure

  2020cites this paper
• Dimethandrolone Undecanoate, a Novel Non-Aromatizable Androgen, Increases P1NP in Healthy Men over 28 days.

  2020cites this paper
• Reflections on the T Trials

  2020cites this paper
• Late‐onset Hypogonadism: Bone health

  2020cites this paper
• The Effects of Androgens on Bone Metabolism: Clinical Aspects

  2020cites this paper
• Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone

  2019cites this paper
• Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency

  2019cites this paper
• Testosterone and male rejuvenation.

  2019cites this paper
• Osteocalcin‐dependent regulation of glucose metabolism and fertility: Skeletal implications for the development of insulin resistance

  2018cites this paper
• Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial

  2018cites this paper
• Application of Transdermal Testosterone inTreatment of Male Hypogonadism

  2018cites this paper
• Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.

  2018cites this paper
• An association between bone mineral density and anabolic hormones in middle-aged and elderly men with prediabetes

  2017cites this paper
• Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.

  2017cites this paper
• Effect of testosterone therapy combined with a very low caloric diet in obese men: a randomised controlled trial

  2017cites this paper
• Testosterone Therapy: Transdermal Androgens

  2017cites this paper
• Stanozolol-soaked grafts enhance new bone formation in rat calvarial critical-size defects

  2017cites this paper
• Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia

  2017cites this paper
• Sex steroids and the kidney: role in renal calcium and phosphate handling.

  2017cites this paper
• Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat?

  2016cites this paper
• Efectos del tratamiento con testosterona en la densidad mineral ósea y la composición corporal en hombres con Síndrome de Déficit de Testosterona

  2016influential citation
• Metabolic syndrome and hypogonadism--two peas in a pod.

  2016cites this paper
• The cumulative effect of bisphosphonates and statins on stress fractures. Is it a failure of steroid biosynthesis? Case Report.

  2016cites this paper
• Benefits and Harms of Testosterone Replacement Therapy in Hypogonadal Men: A Systematic Review and Network Meta-analysis

  2016cites this paper
• TESTOSTERONE AND CARDIOVASCULAR RISK the FDA and to the European Medicines

  2015cites this paper
• Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan

  2015cites this paper
• Effect of a single injection of testosterone enanthate on 17β estradiol and bone turnover markers in hypogonadal male patients

  2015cites this paper
• Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System.

  2015cites this paper
• Current and emerging testosterone therapies for male hypogonadism

  2015cites this paper
• A influência da Sarcopenia na densidade mineral óssea de homens idosos

  2015cites this paper
• Osteoporosis and Low Bone Mineral Density in Men with Testosterone Deficiency Syndrome.

  2015cites this paper
• Testosterone therapy and cardiovascular risk: advances and controversies.

  2015cites this paper
• Transdermal testosterone replacement therapy in men

  2014cites this paper
• Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years

  2014cites this paper
• Musculoskeletal Disorders in Chronic Obstructive Pulmonary Disease

  2014cites this paper
• Testosterone Replacement and Bone Mineral Density in Male Pituitary Tumor Patients

  2014cites this paper
• Experiences and treatment patterns of hypogonadal men in a U.S. health system

  2014cites this paper
• Phase II drugs currently being investigated for the treatment of hypogonadism

  2014cites this paper
• Capítulo 11 – Hipogonadismo masculino y hueso: osteoporosis del varón

  2014cites this paper
• Capítulo 12 – Efectos de la patología del receptor androgénico y estrogénico sobre el hueso

  2014cites this paper
• Biochemical Markers of Bone Turnover in Osteoporosis

  2013cites this paper
• Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome

  2013cites this paper
• Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidence

  2013cites this paper
• Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome

  2013cites this paper
• Testosterone Delivered with a Scaffold Is as Effective as Bone Morphologic Protein-2 in Promoting the Repair of Critical-Size Segmental Defect of Femoral Bone in Mice

  2013cites this paper
• Therapeutic options in male osteoporosis

  2013cites this paper
• Osteoporosis in men

  2013cites this paper
• Behandlung der Osteoporose des Mannes

  2013cites this paper
• Topical Testosterone Supplementation for the Treatment of Male Hypogonadism

  2012influential citation
• Androgens and bone.

  2012cites this paper
• Effects of skin washing on systemic absorption of testosterone in hypogonadal males after administration of 1.62% testosterone gel

  2012cites this paper
• Serum testosterone levels in non-dosed females after secondary exposure to 1.62% testosterone gel: effects of clothing barrier on testosterone absorption

  2012cites this paper
• Effect of application site, clothing barrier, and application site washing on testosterone transfer with a 1.62% testosterone gel

  2012cites this paper
• Effects of short-term testosterone replacement on areal bone mineral density and bone turnover in young hypogonadal males

  2012influential citation
• Androgen Replacement Therapy

  2012cites this paper
• Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

  2012cites this paper
• Osteoporosis in Men - A Crucial Role of Sex Hormones

  2012cites this paper
• Why Is Androgen Replacement in Males Controversial

  2011cites this paper
• Chapter 19 – Testicular Disorders

  2011cites this paper
• Biochemical Bone Turnover Markers and Osteoporosis in Older Men: Where Are We?

  2011influential citation
• Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men.

  2011cites this paper
• Osteoporosis in Men

  2011cites this paper
• Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations.

  2011cites this paper
• A practical guide to male hypogonadism in the primary care setting

  2010cites this paper
• Androgen Actions on Bone: Clinical Aspects

  2010cites this paper
• Treating hypogonadism in younger males

  2010cites this paper
• eview ex steroid metabolism in the regulation of bone health in men

  2010cites this paper
• Male hypogonadism: Symptoms and treatment

  2010cites this paper
• Chapter 35 – Testicular Dysfunction

  2010cites this paper
• Assessment of Bone Turnover in Men Using Biochemical Markers

  2010cites this paper
• Testosterone Therapy for Osteoporosis in Men

  2010cites this paper
• Chapter 34. Biochemical Markers of Bone Turnover in Osteoporosis

  2009cites this paper
• Therapeutic potential of testosterone gels

  2009cites this paper
• Safety and efficacy of testosterone gel in the treatment of male hypogonadism

  2009cites this paper
• Testosterone treatment in elderly men

  2009cites this paper
• Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants

  2009influential citation
• Androgens and bone.

  2009cites this paper
• Estrogens as regulators of bone health in men

  2009cites this paper